CNBX Pharmaceuticals Inc. (CNBX) Other Non Operating Income (2011 - 2026)

CNBX Pharmaceuticals (CNBX) has 14 years of Other Non Operating Income data on file, last reported at $8598.0 in Q2 2026.

• Quarterly Other Non Operating Income rose 144.44% year-over-year to $8598.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$31601.0 (down 12007.66% YoY) and the FY2021 annual result came in at -$594270.0, up 86.57% from the prior year.
• Other Non Operating Income fell to $8598.0 in Q2 2026, from $28865.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $28865.0 in Q1 2026 to a low of -$508610.0 in Q1 2022.
• A 5-year average of -$38658.1 and a median of -$1280.0 in 2024 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2025 — Other Non Operating Income slumped 2100.68% — and 2026, when it soared 672.15%.
• Tracing CNBX's Other Non Operating Income over 5 years: stood at -$10879.0 in 2022, then jumped by 39.12% to -$6623.0 in 2023, then surged by 137.52% to $2485.0 in 2024, then tumbled by 2100.68% to -$49717.0 in 2025, then jumped by 117.29% to $8598.0 in 2026.
• The last three Other Non Operating Income figures came in at $8598.0 (Q2 2026), $28865.0 (Q1 2026), and -$49717.0 (Q4 2025), per Business Quant data.